Welcome to our dedicated page for UNIVERSAL TECHNICAL INSTITUTE SEC filings (Ticker: UTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNIVERSAL TECHNICAL INSTITUTE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNIVERSAL TECHNICAL INSTITUTE's regulatory disclosures and financial reporting.
UTI submitted a Form 144 notice for the proposed sale of Common Stock, listing 10,000 shares and an aggregate amount of $375,000.00, dated 03/04/2026 on the NYSE.
The filing also lists stock awards dated 03/14/2022 for 5,246 shares and 02/22/2023 for 9,895 shares as securities to be sold.
Fidelity Brokerage Services LLC submitted a Form 144 notice relating to up to 16,500 shares of Common Stock. The filing lists two restricted stock vesting entries recorded as compensation: 12/08/2024 for 7,325 shares and 12/13/2024 for 9,175. The cover line shows an aggregate dollar figure of $615,945.00 and a filing date of 03/04/2026.
UNIVERSAL TECHNICAL INSTITUTE INC director and Chief Executive Officer Jerome Alan Grant reported an open-market sale of common stock. He sold 60,040 shares of common stock at a weighted average price of $34.9516 per share on February 27, 2026.
According to the disclosure, these shares were sold for the reporting person’s personal tax planning purposes. After the transaction, Grant directly owned 430,215 shares of UNIVERSAL TECHNICAL INSTITUTE INC common stock. The sale was executed through multiple trades at prices ranging from $34.41 to $35.115 per share.
UTI submitted a Form 144 notice reporting the proposed sale of 30,000 shares of common stock through Fidelity Brokerage Services LLC, with the form dated 03/02/2026. The filing lists restricted stock vesting events totaling 28,203 shares on 12/08/2025 and 1,797 shares on 12/15/2025.
The filing identifies an aggregate value of $1,109,822.21 associated with the 30,000 shares and shows an NYSE listing. The notice documents the planned disposition method and vesting origins rather than an open‑market execution detail.
UTI submitted a Form 144 notice describing proposed sales of Common Stock tied to multiple restricted stock vesting lots. The filing lists vesting dates and quantities such as 1,625 shares (09/05/2015), 2,772 shares (01/07/2022), and 3,356 shares (12/08/2022).
The filing names Fidelity Brokerage Services LLC as the broker-dealer and includes an entry dated 03/02/2026 with an NYSE designation.
Universal Technical Institute, Inc. senior vice president and chief HR officer Carolyn Ann Frank reported an open-market sale of company stock. On 02/13/2026, she sold 1,750 shares of common stock at a price of $30.077 per share. After this transaction, she directly owned 30,272 shares of Universal Technical Institute common stock.
A holder of Universal Technical Institute (UTI) common stock has filed a Rule 144 notice to sell 1,750 shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $52,634.23 and an approximate sale date of February 13, 2026.
The shares being sold were acquired on January 16, 2025 through restricted stock vesting from the issuer as compensation. The notice lists 55,020,506 issuer shares outstanding, which serves as a baseline figure for the company’s equity.
Universal Technical Institute, Inc. delivered revenue of $220.8 million for the quarter ended December 31, 2025, up 9.6% from a year earlier, driven by 7.2% growth in average full‑time active students across its UTI and Concorde segments. Net income declined to $12.8 million from $22.2 million, as operating margin compressed to 7.1% from 13.6% due to higher compensation, marketing, and other expenses tied to its multi‑year growth strategy.
UTI segment revenue rose 8.6% to $142.8 million, while Concorde grew 11.5% to $78.0 million, both benefiting from higher student volumes. Diluted EPS was $0.23 versus $0.40. Operating cash flow fell to $3.1 million, reflecting timing of receivables, prepaid items, payables, and higher use of proprietary student financing, while the company stepped up capital spending to support new campuses and program expansions.
UTI ended the quarter with $93.6 million in cash and cash equivalents, $69.2 million in short‑term investments, and $70.4 million of undrawn revolver capacity, for total liquidity of $233.2 million. Long‑term debt stood at $101.7 million, mainly from property term loans and borrowings under its credit facility.
Universal Technical Institute, Inc. furnished materials related to its fiscal 2026 first quarter on a current report. The company issued a press release reporting its first quarter 2026 results, which is included as Exhibit 99.1.
It also made available an investor presentation (Exhibit 99.2) and a Q1 2026 financial supplement (Exhibit 99.3) on its investor relations website for use in meetings with investors and analysts. These materials are provided for information purposes and are furnished rather than filed under securities laws.